The Russell 2000 Index has soared, but you -2-
Omega Therapeutics Inc. OMGA 100% $3.01 $12.00 299% Allogene Therapeutics Inc. ALLO 82% $3.21 $12.79 298% X4 Pharmaceuticals Inc. XFOR 86% $0.84 $3.26 289% Caribou Biosciences Inc. CRBU 89% $5.73 $22.25 288% Stoke Therapeutics Inc. STOK 78% $5.26 $19.33 268% Source: FactSet
That's right - this Russell 2000 list is all biotech. And in case you are wondering if any companies are on both lists, the answer is no.
Don't miss: 11 dividend stocks with high yields expected to be well supported in 2024 per strict criteria
-Philip van Doorn
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-06-24 0558ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations